Verdence Capital Advisors LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 214 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

Quarter-by-quarter ownership
Verdence Capital Advisors LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$551,379
+4.5%
14,434
-1.3%
0.06%
-1.6%
Q2 2023$527,488
-4.2%
14,624
+1.4%
0.06%
-9.0%
Q1 2023$550,623
-34.4%
14,418
-2.3%
0.07%
-35.0%
Q4 2022$839,958
+35.5%
14,762
-5.8%
0.10%
+19.8%
Q3 2022$620,000
-9.2%
15,676
+1.0%
0.09%
-2.3%
Q2 2022$683,000
+22.2%
15,528
+10.7%
0.09%
+39.7%
Q1 2022$559,000
+0.9%
14,021
+1.8%
0.06%
-3.1%
Q4 2021$554,000
+18.6%
13,770
+19.9%
0.06%
+6.6%
Q3 2021$467,000
-10.5%
11,488
-0.1%
0.06%
-15.3%
Q2 2021$522,000
+8.5%
11,495
-0.3%
0.07%
-11.1%
Q1 2021$481,000
-2.4%
11,531
-0.2%
0.08%
-12.9%
Q4 2020$493,000
+64.9%
11,551
+1.4%
0.09%
+34.8%
Q3 2020$299,000
-2.0%
11,3880.0%0.07%
-8.0%
Q2 2020$305,000
+48.8%
11,3880.0%0.08%
+23.0%
Q1 2020$205,000
+1.5%
11,3880.0%0.06%
+24.5%
Q4 2019$202,000
+14.1%
11,3880.0%0.05%
-2.0%
Q3 2019$177,000
-9.7%
11,3880.0%0.05%
-10.7%
Q2 2019$196,000
+7.1%
11,3880.0%0.06%
+12.0%
Q1 2019$183,000
+9.6%
11,3880.0%0.05%
+6.4%
Q4 2018$167,000
-19.3%
11,3880.0%0.05%
-7.8%
Q3 2018$207,000
+7.8%
11,3880.0%0.05%
+8.5%
Q2 2018$192,000
-13.9%
11,3880.0%0.05%
-13.0%
Q1 2018$223,000
-3.5%
11,3880.0%0.05%
-1.8%
Q4 2017$231,00011,3880.06%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,506,473$61,283,0005.13%
First Light Asset Management, LLC 1,477,496$60,105,0003.96%
SNYDER CAPITAL MANAGEMENT L P 3,427,476$139,430,0003.69%
DOHENY ASSET MANAGEMENT /CA 80,400$3,271,0002.34%
Redwood Investments, LLC 619,766$25,212,0002.11%
HighMark Wealth Management LLC 53,341$2,170,0001.60%
SILVERARC CAPITAL MANAGEMENT, LLC 60,170$2,448,0001.38%
Third Security, LLC 168,604$6,859,0001.33%
Taylor Wealth Management Partners 87,654$3,566,0001.27%
Penn Capital Management Company, LLC 290,394$11,813,0001.19%
View complete list of HALOZYME THERAPEUTICS INC shareholders